EQUITY (Tables)
|
9 Months Ended |
Sep. 30, 2025 |
|---|
| Equity [Abstract] |
|
| Schedule of Warrants Outstanding and Exercisable |
The following table summarizes the status of warrants and related transactions: | | | | | | | | | | | | | | | | | | | | | | | | | Non-Derivative (Equity) Warrants | | Derivative Liabilities Warrants | | Total Number of Warrants | | Weighted - Average Exercise Price | Balance as of January 1, 2025 | 50,518,536 | | 21,400,000 | | 71,918,536 | | $ | 1.03 | | Granted (1) | 8,210,626 | | | — | | | 8,210,626 | | | $ | 0.48 | | | | | | | | | | | | | | | | | | | | | | | | | | Balance as of September 30, 2025 | 58,729,162 | | 21,400,000 | | 80,129,162 | | $ | 0.98 | | Exercisable as of September 30, 2025 | 57,509,162 | | 21,400,000 | | 78,909,162 | | $ | 0.98 | |
|
| Schedule of Share-Based Payment Award, Warrants, Valuation Assumptions |
The following assumptions were used for the calculation at date of issuance: | | | | | | | Weighted average stock price | $0.33 | | Weighted average expected stock price volatility | 91.8% | | Expected annual dividend yield | 0% | Weighted average expected life of warrants | 5.0 years | | Weighted average risk-free annual interest rate | 4.1% | | Weighted average grant date fair value | $0.22 |
|
| Schedule of Stock Options Outstanding |
The following table summarizes the status of stock options and related transactions: | | | | | | | | | | | | | Number of Stock Options | | Weighted-Average Per Share Exercise Price | | Issued and Outstanding as of January 1, 2025 | 26,769,419 | | | $ | 0.79 | | | Granted | 1,120,000 | | | $ | 0.42 | | | | | | | Cancelled/forfeited/expired | (3,444,834) | | | $ | 0.82 | | | Issued and Outstanding as of September 30, 2025 | 24,444,585 | | | $ | 0.77 | | | Exercisable as of September 30, 2025 | 18,507,055 | | | $ | 0.85 | |
|
| Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions |
The following assumptions were used for the calculation at date of grant: | | | | | | | | | | | | | Nine Months Ended September 30, | | 2025 | | 2024 | | Weighted average stock price | $0.41 | | $0.56 | | Weighted average expected stock price volatility | 92.8% | | 86.9% | | Expected annual dividend yield | 0% | | 0% | | Weighted average expected life | 5.1 years | | 5.0 years | | Weighted average risk-free annual interest rate | 3.9% | | 3.6% | | Weighted average grant date fair value | $0.30 | | $0.21 |
|
| Schedule of Components of Share-based Compensation Expense |
The components of share-based compensation expense, net, are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2025 | | 2024 | | 2025 | | 2024 | Stock options | $ | 261 | | | $ | 982 | | | $ | 187 | | | $ | 2,931 | | | Restricted stock | — | | | — | | | — | | | 2 | | | Warrants | 96 | | | 100 | | | 237 | | | 20 | | Total share-based compensation expense, net | $ | 357 | | | $ | 1,082 | | | $ | 424 | | | $ | 2,953 | |
|